AIZ
63
6
SHW
61
3
GIS
49
2
CMG
66
2
DOV
72
3
AON
50
3
NAVI
22
-11
OKE
55
2
CL
72
3
INTC
49
9
CI
46
-12
WM
80
4
ROK
48
4
VLO
35
2
ZTS
34
-15
HRB
79
6
HIG
71
4
WFC
58
3
WDC
53
3
TAP
31
2
AIZ
63
6
SHW
61
3
GIS
49
2
CMG
66
2
DOV
72
3
AON
50
3
NAVI
22
-11
OKE
55
2
CL
72
3
INTC
49
9
CI
46
-12
WM
80
4
ROK
48
4
VLO
35
2
ZTS
34
-15
HRB
79
6
HIG
71
4
WFC
58
3
WDC
53
3
TAP
31
2
Financhill
Back

Johnson Matthey PLC Vs. Spyre Therapeutics Industry Stock Comparison

Sell
16

JMPLF
Johnson Matthey PLC

Last Price:
20.00
Seasonality Move:
-6.12%
Sell
39

SYRE
Spyre Therapeutics

Last Price:
25.33
Seasonality Move:
49.76%
Sell
16
Johnson Matthey PLC (JMPLF) is a Sell

Is Johnson Matthey PLC a Buy, Sell or Hold?

  • The current Johnson Matthey PLC [JMPLF] share price is $20.00. The Score for JMPLF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • JMPLF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JMPLF Stock Price Chart

What is Johnson Matthey PLC's stock price today?

  • The Johnson Matthey PLC share price today is $20.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JMPLF is experiencing buying pressure, which is a positive indicator for future bullish movement.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $25.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

JMPLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 9.03 Sell
Chaikin Money Flow: 462 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.99 - 23.61) Sell
Bollinger Bands (100): (20.51 - 23.61) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 31.35 Sell
Chaikin Money Flow: -1780910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.05 - 37.75) Sell
Bollinger Bands (100): (27.4 - 39.18) Sell

JMPLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.75 Sell
20-day SMA: 22.68 Sell
50-day SMA: 22.78 Sell
200-day SMA: 21.03 Sell
8-day EMA: 21.73 Sell
20-day EMA: 22.34 Sell
50-day EMA: 22.56 Sell
200-day EMA: 22.01 Sell

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.63 Sell
20-day SMA: 34.16 Sell
50-day SMA: 35.1 Sell
200-day SMA: 24.22 Buy
8-day EMA: 32.34 Sell
20-day EMA: 33.91 Sell
50-day EMA: 34.32 Sell
200-day EMA: 27.18 Sell

Johnson Matthey PLC Earnings Growth & JMPLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

Johnson Matthey PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):